Madhav Thambisetty

Summary

Affiliation: King's College London
Country: UK

Publications

  1. ncbi request reprint Hypertensive brainstem encephalopathy: clinical and radiographic features
    Madhav Thambisetty
    Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA
    J Neurol Sci 208:93-9. 2003
  2. ncbi request reprint Diagnosis and management of MELAS
    Madhav Thambisetty
    Department of Neurology, Institute of Psychiatry, King s College London, UK
    Expert Rev Mol Diagn 4:631-44. 2004
  3. ncbi request reprint Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers
    Simon Lovestone
    Institute of Psychiatry, MRC Centre for Neurodegeneration Research and NIHR Biomedical Research Centre, KCL, London, UK
    Expert Rev Proteomics 4:227-38. 2007
  4. doi request reprint Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease
    Madhav Thambisetty
    King s College London, MRC Centre for Neurodegeneration Research, Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
    J Neurol 255:1712-20. 2008
  5. doi request reprint A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease
    Nicola Greenberg
    Pharmaceutical Sciences Research Division, King s College London, London, UK
    Electrophoresis 30:1235-9. 2009
  6. pmc Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease
    Madhav Thambisetty
    King s College London, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, England
    Arch Gen Psychiatry 67:739-48. 2010

Detail Information

Publications6

  1. ncbi request reprint Hypertensive brainstem encephalopathy: clinical and radiographic features
    Madhav Thambisetty
    Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA
    J Neurol Sci 208:93-9. 2003
    ..The clinical findings and neuroimaging abnormalities resolve with treatment of the hypertension, further distinguishing this syndrome from brainstem infarction...
  2. ncbi request reprint Diagnosis and management of MELAS
    Madhav Thambisetty
    Department of Neurology, Institute of Psychiatry, King s College London, UK
    Expert Rev Mol Diagn 4:631-44. 2004
    ..Newer reproductive technologies hold promise for reducing the recurrence of MELAS in subsequent generations. Advances in research into gene therapy offer hope of treatment for the future...
  3. ncbi request reprint Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers
    Simon Lovestone
    Institute of Psychiatry, MRC Centre for Neurodegeneration Research and NIHR Biomedical Research Centre, KCL, London, UK
    Expert Rev Proteomics 4:227-38. 2007
    ....
  4. doi request reprint Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease
    Madhav Thambisetty
    King s College London, MRC Centre for Neurodegeneration Research, Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
    J Neurol 255:1712-20. 2008
    ..We also undertook a proteomic analysis of plasma in these individuals using two-dimensional gel electrophoresis (2DGE)...
  5. doi request reprint A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease
    Nicola Greenberg
    Pharmaceutical Sciences Research Division, King s College London, London, UK
    Electrophoresis 30:1235-9. 2009
    ..This study suggested that further investigation into the lipid fraction of the metabolome may yield useful biomarkers for AD and metabolomic profiles could be used to predict disease state in a clinical setting...
  6. pmc Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease
    Madhav Thambisetty
    King s College London, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, England
    Arch Gen Psychiatry 67:739-48. 2010
    ..Blood-based analytes may be indicators of pathological processes in Alzheimer disease (AD)...